NCT07579338

Brief Summary

This case-control study will be conducted between January and June 2026 and will include 148 participants aged over 30 years to investigate differences between individuals with periodontitis (n = 111) and those with periodontal health (n = 37). Participants will be selected based on strict inclusion and exclusion criteria to minimize confounding factors, and ethical approval along with informed consent will be obtained prior to participation. Periodontitis will be diagnosed according to the 2017 classification criteria, requiring clinical attachment loss and periodontal pocketing, while periodontal health will be defined by minimal bleeding on probing, shallow pocket depths, and absence of attachment loss. The sample size will be determined using G\*Power to ensure adequate statistical power. Clinical periodontal parameters-including plaque index, gingival bleeding index, probing pocket depth, and clinical attachment loss-will be recorded using standardized methods at multiple sites per tooth by calibrated examiners to ensure reliability. Following clinical assessment, subgingival biofilm samples will be collected using sterile paper points under controlled conditions and stored at -80°C for subsequent real-time PCR analysis. Calibration procedures, including inter- and intra-examiner agreement assessed by intraclass correlation coefficients, will be implemented to enhance measurement consistency. Overall, the study will combine rigorous clinical evaluation with molecular techniques to enable a comprehensive assessment of periodontal status and associated microbiological factors.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P50-P75 for all trials

Timeline
2mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Jan 2026Aug 2026

Study Start

First participant enrolled

January 31, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 12, 2026

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

May 12, 2026

Status Verified

May 1, 2026

Enrollment Period

4 months

First QC Date

May 6, 2026

Last Update Submit

May 6, 2026

Conditions

Keywords

periodontitisPlaqueE.saphenumP. gingivalis

Outcome Measures

Primary Outcomes (1)

  • The level of E. saphenum in periodontitis and periodontal health groups.

    Measuring the level of E. saphenum and P. ginigvalis in study groups using Real-time PCR

    8 MONTHS

Secondary Outcomes (1)

  • Comparing the level of E. saphenum and P. gingivalis between study groups.

    8 months

Study Arms (2)

Peiordontal health

In the control group, the participants were diagnosed periodontal health characterized by BOP \< 10%, PPD ≤ 3mm, and intact periodontium with no probable attachment loss (Chapple et al., 2018)

Diagnostic Test: Microbiological sampling After recording the clinical periodontal parameters, subgingival biofilm samples were collected. After selecting the sampling site, it was isolated with cotton rolls to keep i

Periodontitis

Participants were diagnosed as periodontitis when they have interdental CAL detectable at ≥2 non-adjacent teeth, or facial and/or oral CAL ≥3 mm associated with pocketing \>3mm detectable at ≥ 2 teeth. The diagnosis statement was: Generalized periodontitis (\>30% of teeth having CAL), Unstable status (having at least one site with PPD ≥5 mm or PPD ≥4 mm with BOP), at stages I-IV (Tonetti, Greenwell and Kenneth S. Kornman, 2018)

Diagnostic Test: Microbiological sampling After recording the clinical periodontal parameters, subgingival biofilm samples were collected. After selecting the sampling site, it was isolated with cotton rolls to keep i

Interventions

Microbiological sampling After recording the clinical periodontal parameters, subgingival biofilm samples were collected. After selecting the sampling site, it was isolated with cotton rolls to keep it dry and avoid saliva contamination. Then, a sterile paper point will be gently inserted into the selected sites reaching the base of the pocket and will be kept for 30 seconds. Then, the paper point will be carefully withdrawn and placed immediately into a sterile tube containing a preservative solution. The tube will be labeled with details, including the patient ID, site location, and date, and then sealed tightly to prevent contamination. The sample was stored at -80°C to preserve DNA quality for subsequent Real time-PCR analysis.

Peiordontal healthPeriodontitis

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study is an observational case-control study. Patients with generalized unstable periodontitis, at any grade, with (\>4 mm) probing pocket depths (PPD), as well as periodontal health participants, will be recruited from the Department of Periodontics, College of Dentistry, University of Babylon. A written consent forms will be obtained from all participants. Ethical approval will be obtained.

You may qualify if:

  • (1) Participants aged \> 30 years old. (2) Participants who have at least 20 teeth

You may not qualify if:

  • \) Participants who have active caries. (2) Participants who are undergoing orthodontic treatment. (3) Participants with a history of antibiotic use within the last three months will not be eligible.
  • (4) Participants with a history of valve replacement which requires prophylactic antibiotic coverage. (5) Participants who require systemic or topical non-steroidal anti-inflammatory drugs within the past three months. Participants who are pregnant or lactating women. (6) Participants with a history of alcohol use. (7) Participants who had periodontal therapy within the last six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of babylon

Hillah, Babel, 3001, Iraq

Location

Related Publications (1)

  • Castillo Y, Delgadillo NA, Neuta Y, Iniesta M, Sanz M, Herrera D, Pianeta R, Lafaurie GI, Castillo DM. Design and validation of a quantitative polymerase chain reaction test for the identification and quantification of uncultivable bacteria associated with periodontitis. Arch Oral Biol. 2023 Oct;154:105758. doi: 10.1016/j.archoralbio.2023.105758. Epub 2023 Jul 4.

    PMID: 37419062BACKGROUND

MeSH Terms

Conditions

PeriodontitisPlaque, Amyloid

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

May 6, 2026

First Posted

May 12, 2026

Study Start

January 31, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

May 12, 2026

Record last verified: 2026-05

Locations